Cooperation of TLR2 with MyD88, PI3K, and Rac1 in lipoteichoic acid-induced cPLA2/COX-2-dependent airway inflammatory responses

American Journal of Pathology

Volumn 176, Issue 4, 2010, Pages 1671-1684

  Lee, I Ta ^a   Lee, Chiang Wen ^b   Tung, Wei Hsuan ^a   Wang, Shyi Wu ^a   Lin, Chih Chung ^a   Shu, Jwu Ching ^a   Yang, Chuen Mao ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CYCLOOXYGENASE 2; HELENALIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIPOTEICHOIC ACID; MITOGEN ACTIVATED PROTEIN KINASE 9; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE A2; PROTEIN KINASE B; RAC1 PROTEIN; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 2;

ANIMAL EXPERIMENT; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE COUNT; LUNG LAVAGE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RESPIRATORY TRACT DISEASE; SMOOTH MUSCLE FIBER; STAPHYLOCOCCUS AUREUS; TRACHEA;

EID: 77950556544     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.090714     Document Type: Article

References (46)

1. Hirst SJ, Martin JG, Bonacci JV, Chan V, Fixman ED, Hamid QA, Herszberg B, Lavoie JP, McVicker CG, Moir LM, Nguyen TT, Peng Q, Ramos-Barbon D, Stewart AG: Proliferative aspects of airway smooth muscle. J Allergy Clin Immunol 2004, 114:S2-S17 (Pubitemid 39078526)
2. Sutcliffe IC, Shaw N: Atypical lipoteichoic acids of gram-positive bacteria. J Bacteriol 1991, 173:7065-7069
3. Alkan ML, Beachey EH: Excretion of lipoteichoic acid by group A streptococci. Influence of penicillin on excretion and loss of ability to adhere to human oral mucosal cells J Clin Invest 1978, 61:671-677
4. Su SC, Hua KF, Lee H, Chao LK, Tan SK, Lee H, Yang SF, Hsu HY: LTA and LPS mediated activation of protein kinases in the regulation of inflammatory cytokines expression in macrophages. Clin Chim Acta 2006, 374:106-115 (Pubitemid 44572245)
5. Suzuki N, Suzuki S, Yeh WC: IRAK-4 as the central TIR signaling mediator in innate immunity. Trends Immunol 2002, 23:503-506 (Pubitemid 35248046)
6. Liljeroos M, Vuolteenaho R, Morath S, Hartung T, Hallman M, Ojaniemi M: Bruton's tyrosine kinase together with PI 3-kinase are part of Toll-like receptor 2 multiprotein complex and mediate LTA induced Toll-like receptor 2 responses in macrophages. Cell Signal 2007, 19:625-633 (Pubitemid 46107814)
7. Lee IT, Wang SW, Lee CW, Chang CC, Lin CC, Luo SF, Yang CM: Lipoteichoic acid induces HO-1 expression via the TLR2/MyD88/c-Src/NADPH oxidase pathway and Nrf2 in human tracheal smooth muscle cells. J Immunol 2008, 181:5098-5110
8. Barnes PJ: New concepts in the pathogenesis of bronchial hyperresponsiveness and asthma. J Allergy Clin Immunol 1989, 83:1013-1026 (Pubitemid 19170059)
9. Smith LJ: Bioactive mediators in asthma. Chest 1992, 101:381S-384S
10. DeWitt DL: Cox-2-selective inhibitors: the new super aspirins. Mol Pharmacol 1999, 55:625-631
11. 2 enzymes: classification and characterization. Biochim Biophys Acta 2000, 1488:1-19
12. 2. J Biol Chem 1997, 272:16709-16712
13. 2. Nat Immunol 2000, 1:42-46
14. Uozumi N, Kume K, Nagase T, Nakatani N, Ishii S, Tashiro F, Komagata Y, Maki K, Ikuta K, Ouchi Y, Miyazaki J, Shimizu T: Role of cytosolic phospholipase A2 in allergic response and parturition. Nature 1997, 390:618-622 (Pubitemid 28016197)
15. Luo SF, Wang CC, Chien CS, Hsiao LD, Yang CM: Induction of cyclooxygenase-2 by lipopolysaccharide in canine tracheal smooth muscle cells: involvement of p42/p44 and p38 mitogen-activated protein kinases and nuclear factor-κB pathways. Cell Signal 2003, 15:497-509
16. Yang CM, Chien CS, Hsiao LD, Luo SF, Wang CC: Interleukin-1β-induced cyclooxygenase-2 expression is mediated through activation of p42/44 and p38 MAPKS, and NF-κB pathways in canine tracheal smooth muscle cells. Cell Signal 2002, 14:899-911
17. 2, protein kinase A, p38 MAPK, and nuclear factor-κB pathways. Cell Signal 2006, 18:1235-1243
18. 2. Cell Signal 2002, 14:199-204
19. 2 isoforms in the checkpoint control of acute inflammation. FASEB J 2004, 18:489-498
20. Kao SJ, Lei HC, Kuo CT, Chang MS, Chen BC, Chang YC, Chiu WT, Lin CH: Lipoteichoic acid induces nuclear factor-κB activation and nitric oxide synthase expression via phosphatidylinositol 3-kinase, Akt, and p38 MAPK in RAW 264.7 macrophages. Immunology 2005, 115:366-374
21. 2 release and cyclooxygenase-2 synthesis in rat cortical neuronal cells: involvement of PKCε and ERK activation. Life Sci 2006, 79:272-280
22. Chen BC, Kang JC, Lu YT, Hsu MJ, Liao CC, Chiu WT, Yeh FL, Lin CH: Rac1 regulates peptidoglycan-induced nuclear factor-κB activation and cyclooxygenase-2 expression in RAW 264.7 macrophages by activating the phosphatidylinositol 3-kinase/Akt pathway. Mol Immunol 2009, 46:1179-1188
23. Cicenas J: The potential role of Akt phosphorylation in human cancers. Int J Biol Markers 2008, 23:1-9
24. Lee DJ, Cox D, Li J, Greenberg S: Rac1 and Cdc42 are required for phagocytosis, but not NF-κB-dependent gene expression, in macrophages challenged with Pseudomonas aeruginosa. J Biol Chem 2000, 275:141-146 (Pubitemid 30038964)
25. Van AL, Souza-Schorey C: Rho GTPases and signaling networks. Genes Dev 1997, 11:2295-2322
26. Lee CW, Chien CS, Yang CM: Lipoteichoic acid-stimulated p42/p44 MAPK activation via Toll-like receptor 2 in tracheal smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2004, 286:L921-L930
27. You L, Kruse FE, Bacher S, Schmitz ML: Lipoteichoic acid selectively induces the ERK signaling pathway in the cornea. Invest Ophthalmol Vis Sci 2002, 43:2272-2277 (Pubitemid 34700658)
28. Lin A, Karin M: NF-κB in cancer: a marked target. Semin Cancer Biol 2003, 13:107-114
29. Fischer J, Suire C, Hale-Donze H: Toll-like receptor 2 recognition of the microsporidia Encephalitozoon spp. induces nuclear translocation of NF-κB and subsequent inflammatory responses. Infect Immun 2008, 76:4737-4744
30. Lee CW, Lin WN, Lin CC, Luo SF, Wang JS, Pouyssegur J, Yang CM: Transcriptional regulation of VCAM-1 expression by tumor necrosis factor-α in human tracheal smooth muscle cells: involvement of MAPKs. NF-κB, p300, and histone acetylation. J Cell Physiol 2006, 207:174-186
31. Takeda K, Akira S: Toll-like receptors in innate immunity. Int Immunol 2005, 17:1-14
32. Silfani TN, Freeman EJ: Phosphatidylinositide 3-kinase regulates angiotensin II-induced cytosolic phospholipase A2 activity and growth in vascular smooth muscle cells. Arch Biochem Biophys 2002, 402:84-93
33. Pan J, Kao YL, Joshi S, Jeetendran S, Dipette D, Singh US: Activation of Rac1 by phosphatidylinositol 3-kinase in vivo: role in activation of mitogen-activated protein kinase (MAPK) pathways and retinoic acidinduced neuronal differentiation of SH-SY5Y cells. J Neurochem 2005, 93:571-583 (Pubitemid 40617617)
34. Luo SF, Lin WN, Yang CM, Lee CW, Liao CH, Leu YL, Hsiao LD: Induction of cytosolic phospholipase A2 by lipopolysaccharide in canine tracheal smooth muscle cells: involvement of MAPKs and NF-κB pathways. Cell Signal 2006, 18:1201-1211
35. Scott T, Owens MD: Thrombocytes respond to lipopolysaccharide through Toll-like receptor-4, and MAP kinase and NF-κB pathways leading to expression of interleukin-6 and cyclooxygenase-2 with production of prostaglandin E2. Mol Immunol 2008, 45:1001-1008 (Pubitemid 350016336)
36. 2 is phosphorylated and activated by MAP kinase. Cell 1993, 72:269-278
37. Hughes-Fulford M, Li CF, Boonyaratanakornkit J, Sayyah S: Arachidonic acid activates phosphatidylinositol 3-kinase signaling and induces gene expression in prostate cancer. Cancer Res 2006, 66:1427-1433 (Pubitemid 43259923)
38. 4 receptors, protein kinase A, IκB kinase, and NF-κB. J Immunol 2006, 177:681-693
39. 2 synthesis and secretion: the role of PGE2 synthases. Clin Immunol 2006, 119:229-240
40. Keller R, Fischer W, Keist R, Bassetti S: Macrophage response to bacteria: induction of marked secretory and cellular activities by lipoteichoic acids. Infect Immun 1992, 60:3664-3672
41. Ellingsen E, Morath S, Flo T, Schromm A, Hartung T, Thiemermann C, Espevik T, Golenbock D, Foster D, Solberg R, Aasen A, Wang J: Induction of cytokine production in human T cells and monocytes by highly purified lipoteichoic acid: involvement of Toll-like receptors and CD14. Med Sci Monit 2002, 8:BR149-BR156
42. Jordan MS, Singer AL, Koretzky GA: Adaptors as central mediators of signal transduction in immune cells. Nat Immunol 2003, 4:110-116
43. Williams DL, Ozment-Skelton T, Li C: Modulation of the phosphoinositide 3-kinase signaling pathway alters host response to sepsis, inflammation, and ischemia/reperfusion injury. Shock 2006, 25:432-439 (Pubitemid 43755912)
44. Ji RR, Gereau RW, Malcangio M, Strichartz GR: MAP kinase and pain. Brain Res Rev 2009, 60:135-148
45. Eckert RL, Efimova T, Balasubramanian S, Crish JF, Bone F, Dashti S: p38 Mitogen-activated protein kinases on the body surface - a function for p38δ. J Invest Dermatol 2003, 120:823-828 (Pubitemid 36529085)
46. 2 and matrix metalloproteinase-2 correlate with the severity of airflow limitation in stable COPD. Respirology 2008, 13:1014-10211